Summary
Zhaoping Xiong is a technology leader and entrepreneur with 11 years of experience, currently serving as CEO of ProtonUnfold and CTO of AlphaMa, where he applies advanced AI to drug discovery and biopharma problems. He holds a PhD in Data Science and Drug Design from ShanghaiTech and the University of Chinese Academy of Sciences and has deep research and engineering expertise in pretrained LLMs, graph neural networks, representation learning, physics-informed neural networks, and federated learning. Prior roles at Huawei and Tencent sharpened his ability to move models from research into production at scale, and his hands-on background includes building AI-driven drug discovery pipelines. Notably, his early maker and neuroscience visualization projects reflect a curiosity for cross-disciplinary prototyping that informs his product-driven research. Based in Shanghai, he blends academic rigor with startup execution to commercialize cutting-edge AI for therapeutics.
11 years of coding experience
3 years of employment as a software developer
Doctor of Philosophy - PhD Data Science and Drug Design, Doctor of Philosophy - PhD Data Science and Drug Design at ShanghaiTech University
Chinese, English